fluconazole 4% / ibuprofen 2% / itraconazole 1% / terbinafine hcl 4% solution
sincerus florida, llc - ibuprofen (unii: wk2xyi10qm) (ibuprofen - unii:wk2xyi10qm), itraconazole (unii: 304nug5gf4) (itraconazole - unii:304nug5gf4), terbinafine (unii: g7riw8s0xp) (terbinafine - unii:g7riw8s0xp), fluconazole (unii: 8vzv102jfy) (fluconazole - unii:8vzv102jfy) -
ciclopirox 8% / fluconazole 1% / terbinafine hcl 1% solution
sincerus florida, llc - ciclopirox (unii: 19w019zdrj) (ciclopirox - unii:19w019zdrj), fluconazole (unii: 8vzv102jfy) (fluconazole - unii:8vzv102jfy), terbinafine (unii: g7riw8s0xp) (terbinafine - unii:g7riw8s0xp) -
clobetasol propionate 0.05% / niacinamide 4% solution
sincerus florida, llc - clobetasol propionate (unii: 779619577m) (clobetasol - unii:adn79d536h), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) -
betamethasone dipropionate 0.05% / minoxidil 5% solution
sincerus florida, llc - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) -
betamethasone dipropionate 0.05% / minoxidil 5% / niacinamide 2% / pentoxifylline 0.5% solution
sincerus florida, llc - pentoxifylline (unii: sd6qct3tsu) (pentoxifylline - unii:sd6qct3tsu), betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m), minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) -
ribavirin powder, for solution
cameron pharmaceuticals - ribavirin (unii: 49717awg6k) (ribavirin - unii:49717awg6k) - ribavirin for inhalation solution, usp is indicated for the treatment of hospitalized infants and young children with severe lower respiratory tract infections due to rsv. treatment early in the course of severe lower respiratory tract infection may be necessary to achieve efficacy. only severe rsv lower respiratory tract infection should be treated with ribavirin for inhalation solution, usp. the vast majority of infants and children with rsv infection have disease that is mild, self-limited, and does not require hospitalization or antiviral treatment. many children with mild lower respiratory tract involvement will require shorter hospitalization than would be required for a full course of ribavirin for inhalation solution, usp aerosol (3 to 7 days) and should not be treated with the drug. thus the decision to treat with ribavirin for inhalation solution, usp should be based on the severity of the rsv infection. the presence of an underlying condition such as prematurity, immunosuppression or cardiopulmonar
apo-latanoprost solution
apotex inc - latanoprost - solution - 50mcg - latanoprost 50mcg - prostaglandin analogs
pms-latanoprost solution
pharmascience inc - latanoprost - solution - 50mcg - latanoprost 50mcg - prostaglandin analogs
latanoprost solution
laboratoire riva inc. - latanoprost - solution - 50mcg - latanoprost 50mcg - prostaglandin analogs
teva-latanoprost solution
teva canada limited - latanoprost - solution - 50mcg - latanoprost 50mcg - prostaglandin analogs